Ann: European RAT Clinical Trial Halted to Refocus Initiatives, page-160

Hey Semi,

It’s no good putting a blowtorch to the battery division to come up with a deal. The blowtorch should be put to the parasitic collaborators IMO.

They are the ones who are not moving forward. They are content to muddle along, playing with AnteoX for free, for as long as a weak management allows them to. We have been paying “Stealth Mode” Marley a fat bag of coin for 8 months now…for what?

They have achieved what the “industry” wanted; 500 cycles with 80% capacity intact…and no deal. Now watch the goalposts shift. What next?
”Yes, it is good for 500 cycles at 80% but we want it in pink.” FFS!